Mulligan Mobilization vs Transverse Friction Massage in Rotator Cuff Syndrome

July 25, 2023 updated by: Riphah International University

Comparison of Mulligan Mobilization and Transverse Friction Massage in Rotator Cuff Syndrome

The aim of this research is to determine the Effects of Mulligan Mobilization and Transverse Friction Massage in Rotator Cuff Syndrome. Randomized clinical trials will be done at Northwest General Hospital, Peshawar. The sample size is 42. The subjects were divided in two groups, with 21 subjects in Group A and 21 in Group B. Study duration was of 6 months. Sampling technique applied was Non probability Purposive Sampling technique. Both males and females of aged 30-70 years with rotator cuff syndrome from grade (0-3) were included. Tools used in the study are Visual Analogue Scale (VAS), Goniometer, and DASH (Disabilities of the Arm, Shoulder and Hand) questionnaire. Data was analyzed through SPSS 23.

Study Overview

Detailed Description

The rotator cuff syndrome is developed in the subacromial area by compression between the humerus and the coracoacromial arc of the long head of the subacromial bursa and the biceps tendon. The diagnosis of rotator cuff tendonitis and Bursitis is made on the basis of special tests and Examination. The rotator cuff tendons undergo degenerative alterations, the tendons between the humeral head and the coracoacromial arch are compressed and ischemia caused by impingement or elevated intramuscular pressure is all aspects of the physiopathology of RCS.

Highly exposed workers have frequently had RCS associated with biomechanical, psychological, and organizational aspects examined; this could affect generalizations to the entire working population who are exposed to varying degrees of work-related shoulder restrictions. The relationship between work structure and the risk of shoulder illnesses has been rarely investigated. Although various individual factors can raise the incidence of shoulder discomfort and RCS, biomechanical factors are significantly linked to both conditions (e.g., age).

Neer defined the syndrome as impingement of the rotator cuff tendons against the coracoacromial ligament, the anterior edge and undersurface of the anterior part of the acromion, and, often, the acromioclavicular joint. There is consensus that risk factors for shoulder MSDs are upper arm elevation and repeated or prolonged overhead activities in combination with other biomechanical variables (e.g., repetition, force). There is less proof that excessive repetition or rigid shoulder positions are separate risk factors.

The main focus in Rotator Cuff syndrome management is on promoting self-management, reducing pain, optimize function, and modifying the disease process and its effects. The primary treatment for Rotator Cuff syndrome conservatively is physiotherapy which includes strength training, modalities, resistance training and Kinesiotaping. Resistance exercise can reduce Shoulder pain severity and strength in participants with symptomatic Shoulder RCS. Exercise is suggested as the first-line intervention of choice with comparable outcomes but at a lower cost and with fewer associated hazards than surgical therapy in recent randomized controlled studies and systematic reviews. Despite this, there is little evidence that explains what an effective exercise programmed looks like in terms of the kind of exercise, the number of sets and repetitions, tolerable pain levels, duration, and environment.

Mulligan's mobilization with movement (MWM) is a joint mobilization treatment in which the patient actively engages in the uncomfortable action while receiving a manual accessory glide to one of the joint surfaces. Recent research found that in asymptomatic people applying MWM with a postero-lateral glide resulted in less muscular activity in the shoulder muscles . In accordance with Cyriax, Transverse friction massage leads in traumatic hyperemia, which boosts blood flow and lessens discomfort. It also stimulates mechanoreceptors and enhances tissue perfusion.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Khyber Pakhtunkhwa
      • Peshawar, Khyber Pakhtunkhwa, Pakistan, 25000
        • Northwest General Hospital and Research Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Both Male and Female are included
  • Age between 30 to 70
  • Partial rupture and suffering from rotator cuff syndrome(differentiation is made on type of tear from grade 0 to 3)
  • No shoulder surgery
  • Pain on palpation of rotator cuff muscle
  • Two or more provocative tests should be positive which is used to rule out the tendonitis and bursitis.

Exclusion Criteria:

  • Multiple shoulder pathologies.
  • Bursitis
  • Corticosteroid injections last month
  • Orthopedic or cardiovascular problem
  • Recent myocardial infarction or major shoulder trauma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mulligan Mobilzation

MWM technique was carrying out in flexion, abduction, external and internal rotation directions. For this technique, participants were seated on a stretcher, and the physical therapist is standing opposite of the upper extremity that is treated. The internal hand of the physical therapist stabilizes participants' shoulder girdle and, with the thenar eminence of the other hand, performed a glide of the humeral head (this direction is the most suitable for treating such shoulder limitations).

Participants were asked to flex the affected shoulder until the pain started while the physical therapist sustained the gliding force to the humeral head. The single session of MWM technique was last around 20 minutes, in 3 sets of 10 repetitions with a rest interval of 30 seconds between each sets.

Participants were instructed that MWM, including shoulder movement, must be pain-free and should be immediately stopped if any pain is experienced during the treatment.

The single session of MWM technique was last around 20 minutes, in 3 sets of 10 repetitions with a rest interval of 30 seconds between each sets.

Active Comparator: Trasverse Friction Massage
Transverse Friction Massage technique: Patients in the group B were receiving soft tissue massage (deep friction) is made to bend his/ her elbow to 90o and put forearm behind his/ her back, then lean back in half lying position. Thus arm is fixed in adduction and medial rotation. It was given in transverse direction for 10 - 12 minutes. Transverse friction massage was given twice a week with the gap of days for the first 3 week and then the repetition is increased to 3 to 4 times a week for the rest of duration.

Deep friction massage was given to rotator cuff tendon with the tip of index finger, which is reinforced by middle finger.

It was given in transverse direction for 10 - 12 minutes. Transverse friction massage was Given twice a week with the gap of days for the first 3 week and then the repetition is increased to 3 to 4 times a week for the rest of duration.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Disability of Arm, Shoulder and Hand Questionnaire
Time Frame: 6th week
Change from baseline the DASH score at 3rd and 6th week. The DASH (Disabilities of the Arm, Shoulder and Hand) Outcome Measure is a 30-item, self-report questionnaire that measures physical function and symptoms in people with musculoskeletal disorders of the upper limb. Changes from the baseline, and then at 3rd and 6th week
6th week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Visual Analogue Scale
Time Frame: 6th week
Change from baseline the Visual Analogue Scale score at 3rd and 6th week. A device used by physical therapists to measure joints' range of motion. During measurement fulcrum will be placed on shoulder joint parallel to sagittal axis for abduction and adduction, frontal axis for flexion and extension and to humeral longitudinal axis in 90o of abduction for internal and external rotations. Changes from the baseline, and then at 3rd and 6th week
6th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Muhammad Affan Iqbal, PhD*, Riphah International University
  • Principal Investigator: Asad Khan, MSPT*, Northwest General Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2022

Primary Completion (Actual)

June 20, 2023

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

May 4, 2023

First Submitted That Met QC Criteria

May 17, 2023

First Posted (Actual)

May 18, 2023

Study Record Updates

Last Update Posted (Actual)

July 27, 2023

Last Update Submitted That Met QC Criteria

July 25, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe